Treatment(s) already received-None - Page 2 of 13 Posts on Medivizor
Navigation Menu

Treatment(s) already received-None Posts on Medivizor

Comparing accelerated partial-breast irradiation and whole-breast irradiation in patients with early breast cancer.

Comparing accelerated partial-breast irradiation and whole-breast irradiation in patients with early breast cancer.

Posted by on Oct 10, 2020 in Breast cancer | 0 comments

In a nutshell This trial was carried out to assess the long-term results of external-beam accelerated partial-breast irradiation (APBI) intensity-modulated radiation therapy (IMRT) compared to whole-breast irradiation (WBI) in early-stage breast cancer (BC). The authors found that the 10-year recurrence of breast tumors was similar between the 2 methods,...

Read More

Comparing hormone therapy and radiation after breast conserving surgery for older patients with early-stage breast cancer

Comparing hormone therapy and radiation after breast conserving surgery for older patients with early-stage breast cancer

Posted by on Oct 4, 2020 in Breast cancer | 0 comments

In a nutshell This study compared the survival rates for older patients with early-stage breast cancer (BC) receiving hormone therapy (HT), radiation (RT), both or none after breast-conserving surgery (BCS). The data showed that RT and HT in combination and RT alone may lead to higher survival expectancy than HT alone. Some...

Read More

Should azacitidine and venetoclax be used to treat older patients with acute myeloid leukemia?

Should azacitidine and venetoclax be used to treat older patients with acute myeloid leukemia?

Posted by on Sep 27, 2020 in Leukemia | 0 comments

In a nutshell This trial was carried out to assess the effectiveness of azacitidine (Vidaza) in combination with venetoclax (Venclexta) for the treatment of untreated acute myeloid leukemia (AML) in older adults. The authors concluded that this combination prolonged survival and induced more remissions in these patients. Some...

Read More

Treating newly diagnosed Hodgkin lymphoma

Treating newly diagnosed Hodgkin lymphoma

Posted by on Sep 13, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This overview discusses initial treatment options for classical Hodgkin lymphoma (cHL).  Some background Classical HL is a cancer of the lymph nodes. Early-stage (stage I/II) cHL is contained to half the body, while advanced (stage III/IV) has spread to both the upper and lower halves of the body. Both early and advanced cHL have...

Read More

Looking for patients with untreated extensive-stage small cell lung cancer to trial a immunotherapy combination

Looking for patients with untreated extensive-stage small cell lung cancer to trial a immunotherapy combination

Posted by on Aug 15, 2020 in Lung cancer | 0 comments

In a nutshell This trial is examining the effectiveness of atezolizumab (Tecentriq) plus carboplatin (Paraplatin) and etoposide (Etopophos) with or without tiragolumab in patients with untreated extensive-stage small-cell lung cancer (ES-SCLC). The main outcomes that will be measured are progression-free survival (PFS) and overall survival...

Read More

Can androgen deprivation therapy combined with docetaxel plus prednisone improved outcomes in patients with metastatic hormone-sensitive prostate cancer?

Can androgen deprivation therapy combined with docetaxel plus prednisone improved outcomes in patients with metastatic hormone-sensitive prostate cancer?

Posted by on Jul 26, 2020 in Prostate cancer | 0 comments

In a nutshell The aim of this study was to evaluate the safety and effectiveness of combining androgen deprivation therapy (ADT) with docetaxel (Taxotere) plus prednisone (Deltasone) in the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). The study found that this combination improved the outcomes of these...

Read More

Stem cell transplant vs VMP treatment for newly diagnosed multiple myeloma

Stem cell transplant vs VMP treatment for newly diagnosed multiple myeloma

Posted by on Jun 7, 2020 in Multiple Myeloma | 0 comments

In a nutshell This study compared autologous stem cell transplant (SCT) to treatment with the proteasome inhibitor and chemotherapy regimen VMP (bortezomib, melphalan, prednisone) for patients with multiple myeloma (MM). It found that SCT led to better outcomes for the initial treatment of MM. Some background MM is a cancer of the plasma cells, a type...

Read More

Does surgical treatment of early prostate cancer reduce mortality in the long run compared to watchful waiting?

Posted by on Apr 9, 2020 in Prostate cancer | 0 comments

In a nutshell The study compared the long-term outcomes of prostate surgery (radical prostatectomy; RP) and observation (watchful waiting; WW) in patients with early prostate cancer. The study showed that surgery reduced mortality in these patients.  Some background Prostate cancer is one of the most common cancers in American men....

Read More

Surgery followed by chemotherapy improves the outcomes of patients with rectal cancer

Posted by on Oct 13, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of surgery followed by chemotherapy without chemoradiotherapy (CRT) before surgery to treat rectal cancer. Researchers suggested that this treatment improves the outcomes of these patients.  Some background Colorectal cancer is the third most common cancer worldwide. The standard...

Read More